Literature DB >> 19422824

Transport of prion protein across the blood-brain barrier.

W A Banks1, Sandra M Robinson, R Diaz-Espinoza, A Urayama, C Soto.   

Abstract

The cellular form of the prion protein (PrP(c)) is necessary for the development of prion diseases and is a highly conserved protein that may play a role in neuroprotection. PrP(c) is found in both blood and cerebrospinal fluid and is likely produced by both peripheral tissues and the central nervous system (CNS). Exchange of PrP(c) between the brain and peripheral tissues could have important pathophysiologic and therapeutic implications, but it is unknown whether PrP(c) can cross the blood-brain barrier (BBB). Here, we found that radioactively labeled PrP(c) crossed the BBB in both the brain-to-blood and blood-to-brain directions. PrP(c) was enzymatically stable in blood and in brain, was cleared by liver and kidney, and was sequestered by spleen and the cervical lymph nodes. Circulating PrP(c) entered all regions of the CNS, but uptake by the lumbar and cervical spinal cord, hypothalamus, thalamus, and striatum was particularly high. These results show that PrP(c) has bidirectional, saturable transport across the BBB and selectively targets some CNS regions. Such transport may play a role in PrP(c) function and prion replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422824      PMCID: PMC2806677          DOI: 10.1016/j.expneurol.2009.04.025

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  44 in total

1.  Saturable efflux of the peptides RC-160 and Tyr-MIF-1 by different parts of the blood-brain barrier.

Authors:  W A Banks; A J Kastin; H M Sam; V T Cao; B King; L M Maness; A V Schally
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

2.  Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Ming-Fu Chiang; Dah-Ching Ding; Kuo-Wei Li; Shih-Fen Chen; Hui-I Yang; Hung Li
Journal:  J Neurosci       Date:  2005-09-28       Impact factor: 6.167

3.  Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity.

Authors:  Jens Weise; Olaf Crome; Raoul Sandau; Walter Schulz-Schaeffer; Mathias Bähr; Inga Zerr
Journal:  Neurosci Lett       Date:  2004-11-30       Impact factor: 3.046

4.  Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin.

Authors:  W A Banks; J B Jaspan; W Huang; A J Kastin
Journal:  Peptides       Date:  1997       Impact factor: 3.750

5.  Sequestration of centrally administered insulin by the brain: effects of starvation, aluminum, and TNF-alpha.

Authors:  M F Cashion; W A Banks; A J Kastin
Journal:  Horm Behav       Date:  1996-09       Impact factor: 3.587

6.  Leptin enters the brain by a saturable system independent of insulin.

Authors:  W A Banks; A J Kastin; W Huang; J B Jaspan; L M Maness
Journal:  Peptides       Date:  1996       Impact factor: 3.750

7.  Periventricular penetration and disappearance of ICV Tyr-MIF-1, DAMGO, tyrosine, and albumin.

Authors:  L M Maness; W A Banks; J E Zadina; A J Kastin
Journal:  Peptides       Date:  1996       Impact factor: 3.750

Review 8.  Cellular prion protein neuroprotective function: implications in prion diseases.

Authors:  Xavier Roucou; Andréa C LeBlanc
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

9.  Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.

Authors:  L M Maness; W A Banks; M B Podlisny; D J Selkoe; A J Kastin
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

10.  Fate of leptin after intracerebroventricular injection into the mouse brain.

Authors:  L M Maness; A J Kastin; C L Farrell; W A Banks
Journal:  Endocrinology       Date:  1998-11       Impact factor: 4.736

View more
  18 in total

1.  Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice.

Authors:  Karin E Sandoval; Susan A Farr; William A Banks; Michael L Niehoff; John E Morley; Albert M Crider; Ken A Witt
Journal:  Eur J Pharmacol       Date:  2010-12-24       Impact factor: 4.432

2.  Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro.

Authors:  Julia V Georgieva; Dharamdajal Kalicharan; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Dick Hoekstra; Inge S Zuhorn
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

3.  Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Authors:  Yu-Ting Sui; Kristin M Bullock; Michelle A Erickson; Jing Zhang; W A Banks
Journal:  Peptides       Date:  2014-09-30       Impact factor: 3.750

4.  Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake.

Authors:  Akihiko Urayama; Rodrigo Morales; Michael L Niehoff; William A Banks; Claudio Soto
Journal:  FASEB J       Date:  2011-05-09       Impact factor: 5.191

5.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

6.  Plasma prion protein concentration and progression of Alzheimer disease.

Authors:  Christian Schmidt; Harry Becker; Christoph Peter; Katharina Lange; Tim Friede; Inga Zerr
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

7.  CSF prion protein concentration and cognition in patients with Alzheimer disease.

Authors:  Christian Schmidt; Svetlana Artjomova; Martin Hoeschel; Inga Zerr
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

8.  Peripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters.

Authors:  Baian Chen; Claudio Soto; Rodrigo Morales
Journal:  FEBS Lett       Date:  2014-02-01       Impact factor: 4.124

9.  Efficient prion disease transmission through common environmental materials.

Authors:  Sandra Pritzkow; Rodrigo Morales; Adam Lyon; Luis Concha-Marambio; Akihiko Urayama; Claudio Soto
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

10.  Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype.

Authors:  Jean-Noël Arsac; Dominique Bétemps; Eric Morignat; Cécile Féraudet; Anna Bencsik; Denise Aubert; Jacques Grassi; Thierry Baron
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.